BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20499474)

  • 21. Human papillomavirus vaccine: a major public health advance.
    Baltz BL; Hayney MS
    J Am Pharm Assoc (2003); 2006; 46(6):761-2. PubMed ID: 17176694
    [No Abstract]   [Full Text] [Related]  

  • 22. HPV Vaccines: today and in the Future.
    Moscicki AB
    J Adolesc Health; 2008 Oct; 43(4 Suppl):S26-40. PubMed ID: 18809143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV 16/18 prevalence reduced 3 years following vaccine introduction.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(2):254. PubMed ID: 24963520
    [No Abstract]   [Full Text] [Related]  

  • 24. Barriers prevent HPV vaccination in low-income populations.
    AIDS Patient Care STDS; 2010 Jan; 24(1):70. PubMed ID: 20169639
    [No Abstract]   [Full Text] [Related]  

  • 25. The Potential Benefits of HPV Vaccination in Previously Infected Women.
    Schiller JT
    EBioMedicine; 2016 Aug; 10():5-6. PubMed ID: 27515688
    [No Abstract]   [Full Text] [Related]  

  • 26. Free school-based vaccination with HPV vaccine in a Japanese city.
    Fujiwara H; Suzuki M; Yoshinari T; Shiiya K
    Vaccine; 2011 Sep; 29(38):6441-2. PubMed ID: 21704106
    [No Abstract]   [Full Text] [Related]  

  • 27. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.
    Lehtinen M; Apter D
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):326-32. PubMed ID: 26308204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The two faces of human papillomavirus.
    Frazer IH
    Gynecol Oncol; 2010 May; 117(2 Suppl):S4. PubMed ID: 20110119
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: randomized study in healthy girls.
    Schmeink CE; Bekkers RL; Josefsson A; Richardus JH; Berndtsson Blom K; David MP; Dobbelaere K; Descamps D
    Vaccine; 2011 Nov; 29(49):9276-83. PubMed ID: 21856349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
    Gertig DM; Brotherton JM; Saville M
    Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries.
    Wong CA; Saraiya M; Hariri S; Eckert L; Howlett RI; Markowitz LE; Brotherton JM; Sinka K; Martinez-Montañez OG; Kjaer SK; Dunne EF
    Vaccine; 2011 Jan; 29(5):878-85. PubMed ID: 20971113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009.
    Craig BM; Brisson M; Chesson H; Giuliano AR; Jit M
    Clin Ther; 2010 Aug; 32(8):1546-64. PubMed ID: 20728767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus vaccination in HIV-infected women: need for increased coverage.
    Kojic EM; Rana AI; Cu-Uvin S
    Expert Rev Vaccines; 2016; 15(1):105-17. PubMed ID: 26599305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do HPV vaccine genotypes agree with circulating HPV types?
    Tartaglia E; Iafusco D; Galderisi A; Mastrantonio P
    Lancet Infect Dis; 2011 Aug; 11(8):585-6. PubMed ID: 21798460
    [No Abstract]   [Full Text] [Related]  

  • 38. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV vaccines: what remains to be done? Interview by Lauren Constable.
    Zur Hausen H
    Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-preventive care: challenges and opportunities for adolescent HPV vaccination.
    Vadaparampil ST; Perkins R
    Hum Vaccin Immunother; 2014; 10(9):2557-8. PubMed ID: 25483473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.